Literature DB >> 12237317

Mapping the type I collagen-binding site on pigment epithelium-derived factor. Implications for its antiangiogenic activity.

Christina Meyer1, Luigi Notari, S Patricia Becerra.   

Abstract

Pigment epithelium-derived factor (PEDF), a neurotrophic and antiangiogenic serpin, is identified in tissues rich in collagen, e.g. cornea, vitreous, bone, and cartilage. We show that recombinant human PEDF formed complexes with collagens from the bovine cornea and vitreous. We have examined the direct binding of PEDF to collagen I and found that interactions were ionic in nature and occurred when PEDF and collagen I were both in solution, when either one was immobilized, or even when collagen I was denatured under reducing conditions. (125)I-PEDF bound to immobilized collagen I in a saturable fashion (K(D) = 123 nm). Compared with neurotrophic PEDF-derived peptides, ovalbumin and angiogenic inhibitors, only full-length PEDF competed efficiently with (125)I-PEDF for the binding to immobilized collagen I (EC(50) = 3 microg/ml). The collagen-binding region was analyzed using controlled proteolysis and chemically modified PEDF. Cleavage of the serpin exposed loop did not prevent binding to collagen I. Conjugation of lysines with fluorescein increased the collagen binding affinity. However, treatment of PEDF with 1-ethyl-3-(3-dimethylaminopropyl)carbodiimide abolished it, implicating the PEDF aspartic and/or glutamic acid residues in its interaction with collagen I. A negatively charged region on the surface of the PEDF molecule is rich in acidic residues (Glu(41), Glu(42), Glu(43), Asp(44), Asp(64), Asp(256), Asp(258), Glu(290), Glu(291), Glu(296), Asp(300), Glu(304)) available to interact directly with positively charged areas of collagen. This represents the first collagen-binding site described for a serpin, which in PEDF, is distinct from its heparin-binding region, neurotrophic active site, and its serpin exposed loop. The collagen-binding property of PEDF may play a role in surface localization and modulation of its antiangiogenic effects in the eye and bone.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12237317     DOI: 10.1074/jbc.M208339200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  41 in total

1.  Inhibition of tumor cell surface ATP synthesis by pigment epithelium-derived factor: implications for antitumor activity.

Authors:  Monika Deshpande; Luigi Notari; Preeti Subramanian; Vicente Notario; S Patricia Becerra
Journal:  Int J Oncol       Date:  2012-04-10       Impact factor: 5.650

2.  Pigment epithelium-derived factor blocks tumor extravasation by suppressing amoeboid morphology and mesenchymal proteolysis.

Authors:  Omar Ladhani; Cristina Sánchez-Martinez; Jose L Orgaz; Benilde Jimenez; Olga V Volpert
Journal:  Neoplasia       Date:  2011-07       Impact factor: 5.715

3.  Pigment epithelium-derived factor binds to hyaluronan. Mapping of a hyaluronan binding site.

Authors:  S Patricia Becerra; L Alberto Perez-Mediavilla; John E Weldon; Silvia Locatelli-Hoops; Preenie Senanayake; Luigi Notari; Vicente Notario; Joe G Hollyfield
Journal:  J Biol Chem       Date:  2008-09-19       Impact factor: 5.157

4.  Assays for the antiangiogenic and neurotrophic serpin pigment epithelium-derived factor.

Authors:  Preeti Subramanian; Susan E Crawford; S Patricia Becerra
Journal:  Methods Enzymol       Date:  2011       Impact factor: 1.600

5.  Corneal angiogenic privilege: angiogenic and antiangiogenic factors in corneal avascularity, vasculogenesis, and wound healing (an American Ophthalmological Society thesis).

Authors:  Dimitri T Azar
Journal:  Trans Am Ophthalmol Soc       Date:  2006

6.  Pigment-epithelium-derived factor (PEDF) occurs at a physiologically relevant concentration in human blood: purification and characterization.

Authors:  Steen V Petersen; Zuzana Valnickova; Jan J Enghild
Journal:  Biochem J       Date:  2003-08-15       Impact factor: 3.857

Review 7.  The yin and yang of VEGF and PEDF: multifaceted neurotrophic factors and their potential in the treatment of Parkinson's Disease.

Authors:  Torsten Falk; Robert T Gonzalez; Scott J Sherman
Journal:  Int J Mol Sci       Date:  2010-08-05       Impact factor: 5.923

Review 8.  The effects of PEDF on cancer biology: mechanisms of action and therapeutic potential.

Authors:  S Patricia Becerra; Vicente Notario
Journal:  Nat Rev Cancer       Date:  2013-03-14       Impact factor: 60.716

9.  Inhibition of orthotopic osteosarcoma growth and metastasis by multitargeted antitumor activities of pigment epithelium-derived factor.

Authors:  Eugene T H Ek; Crispin R Dass; Karla G Contreras; Peter F M Choong
Journal:  Clin Exp Metastasis       Date:  2007-04-18       Impact factor: 5.150

10.  VEGF ameliorates pulmonary hypertension through inhibition of endothelial apoptosis in experimental lung fibrosis in rats.

Authors:  Laszlo Farkas; Daniela Farkas; Kjetil Ask; Antje Möller; Jack Gauldie; Peter Margetts; Mark Inman; Martin Kolb
Journal:  J Clin Invest       Date:  2009-04-20       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.